Literature DB >> 92700

Circulating prostacyclin may be reduced in diabetes.

C T Dollery, L A Friedman, C N Hensby, E Kohner, P J Lewis, M Porta, J Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 92700     DOI： 10.1016/s0140-6736(79)92844-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

Review 2.  Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes.

Authors:  M Porta
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

3.  15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease.

Authors:  B N Setty; M J Stuart
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 4.  Prostaglandins in vascular disease: a seminal approach.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

Review 5.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

Review 6.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

8.  Prostacyclin and thromboxane in diabetes.

Authors:  O Ylikorkala; J Kaila; L Viinikka
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-31

9.  In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy.

Authors:  T M Davis; E Bown; D R Finch; M D Mitchell; R C Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

10.  Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.

Authors:  G L Shepherd; P J Lewis; I A Blair; C de Mey; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.